{"id":"W1730503696","doi":"10.3747/co.2007.107","title":"Addition of Lenalidomide to Melphalan in the Treatment of Newly Diagnosed Multiple Myeloma: The National Cancer Institute of Canada Clinical Trials Group MY.11 Trial","year":2007,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Multiple myeloma; Melphalan; Tolerability; Oncology; Internal medicine; Clinical trial; Prednisone; Randomized controlled trial; Cancer; Surgery; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002785929,0.001137021,0.00224379,0.0003469888,0.001221095,0.001716363,0.001347538,0.001990635,0.006075553],"category_scores_gemma":[0.002819985,0.0004709914,0.00168036,0.000930033,0.0009215324,0.0005821277,0.0005342611,0.003608301,0.0007066837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01319623,"about_ca_system_score_gemma":0.0224264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3062788,"about_ca_topic_score_gemma":0.6926702,"domain_scores_codex":[0.9985427,0.0006700662,0.000054169,0.0001838179,0.0003109892,0.0002382363],"domain_scores_gemma":[0.9982494,0.0002035145,0.0002899133,0.00007955557,0.0002932118,0.0008844909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7262903,0.004944709,0.006137074,0.00366681,0.004589978,0.0003298939,0.0002542068,0.00222953,0.00417203,0.00203948,0.1108744,0.1344716],"study_design_scores_gemma":[0.9006617,0.01924144,0.02546934,0.0007224024,0.002312423,0.000219359,0.0001248766,0.001340394,0.0005693697,0.0007574189,0.04849742,0.00008380714],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6571568,0.138225,0.001680306,0.0568416,0.004557523,0.01950644,0.05096994,0.0004405998,0.07062182],"genre_scores_gemma":[0.8320196,0.04698552,0.005345985,0.03639212,0.001714812,0.01073781,0.02586025,0.0001274164,0.04081647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3062788,"threshold_uncertainty_score":0.6089921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3644684821070608,"score_gpt":0.5368155580575764,"score_spread":0.1723470759505156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}